Latest in NHS

Destiny Pharma receives US FDA QIDP designation for novel antibacterial product

Lead drug product in development for the prevention of post-surgical Staphyloccocal infections

Find out more
Destiny Pharma receives US FDA QIDP designation for novel antibacterial product

Clinisys unveils governed AI roadmap for connected laboratories

Clinisys unveils governed AI roadmap for connected laboratories

Connected Laboratory Intelligence links trusted data, analytics, agents and automation to help laboratories move from insight to action
See more
From Indonesia to the world: support Beta Pharmacon’s manufacturing excellence with GEA granulation technology

From Indonesia to the world: support Beta Pharmacon’s manufacturing excellence with GEA granulation technology

By integrating GEA granulation technology into its new facility, Beta Pharmacon has enhanced process control, reinforced its commitment to regulatory compliance, and secured GMP and USP qualifications to supply essential micronutrient supplements